NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation [Yahoo! Finance]
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage [Yahoo! Finance]
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues [Yahoo! Finance]
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues